Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TYMS | P04818 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL77594 | 0.76 | ACHE (0.36) | ACHE | |
| SCHEMBL4016319 | 0.72 | KDM4E (0.37) | KDM4ESIRT2TYMS | |
| SCHEMBL78463 | 0.71 | ACHE (0.40) | ACHEMEN1KMT2ATYMS | |
| SCHEMBL78870 | 0.69 | KDM4E (0.33) | KDM4E | |
| SCHEMBL23932622 | 0.69 | KDM4E (0.48) | KDM4EPOLBKMT2A | |
| SCHEMBL3669349 | 0.64 | ACHE (0.37) | ACHEKDM4EMEN1RAB9AKMT2A | |
| SCHEMBL4017362 | 0.64 | KDM4E (0.34) | KDM4EPOLB | |
| SCHEMBL2047790 | 0.62 | ACHE (0.58) | ACHESIRT2TYMS | |
| SCHEMBL27907963 | 0.62 | ALDH1A1 (0.46) | KDM4EPOLBMEN1KMT2A | |
| SCHEMBL139002 | 0.61 | ALDH1A1 (0.65) | KDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129488-B2 | Transition metal complexes, catalyst compositions containing the same, and olefin polymerization using the catalyst compositions | LG CHEM, LTD. (KR) | 2012-03-06 | — | — | US | disclosed |
| US-20090209712-A1 | TRANSITION METAL COMPLEXES, CATALYST COMPOSITIONS CONTAINING THE SAME, AND OLEFIN POLYMERIZATION USING THE CATALYST COMPOSITIONS | LG CHEM., LTD. (KR) | 2009-08-20 | — | — | US | disclosed |
| US-7538239-B2 | Transition metal complexes, catalyst compositions containing the same, and olefin polymerization using the catalyst compositions | LG CHEM, LTD. (KR) | 2009-05-26 | — | — | US | disclosed |
| US-7531608-B2 | Transition metal complexes, catalyst compositions containing the same, and olefin polymerization using the catalyst compositions | LG CHEM, LTD. (KR) | 2009-05-12 | — | — | US | disclosed |
| WO-2007007991-A1 | TRANSITION METAL COMPLEXES, CATALYST COMPOSITIONS CONTAINING THE SAME, OLEFIN POLYMERIZATION USING THE CATALYST COMPOSITIONS | LG CHEM, LTD. (KR) | 2007-01-18 | — | — | WO | disclosed |
| WO-2007007992-A1 | TRANSITION METAL COMPLEXES, CATALYST COMPOSITIONS CONTAINING THE SAME, AND OLEFIN POLYMERIZATION USING THE CATALYST COMPOSITIONS | LG CHEM, LTD. (KR) | 2007-01-18 | — | — | WO | disclosed |
| US-20070010638-A1 | Transition metal complexes, catalyst compositions containing the same, and olefin polymerization using the catalyst compositions | LG CHEM, LTD. (KR) | 2007-01-11 | — | — | US | disclosed |
| US-20070010637-A1 | Transition metal complexes, catalyst compositions containing the same, and olefin polymerization using the catalyst compositions | LG CHEM, LTD. (KR) | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010638-A1 | Transition metal complexes, catalyst compositions containing the same, and olefin polymerization using the catalyst compositions | CPNE4, AOC2, ODC1 | ACHE 2411/4885KDM4E 2895/4885SIRT2 3658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.